|
|  |
Washington University in St. Louis News & Information > Faculty Experts at Washington University in St. Louis >
Wilma and Roswell Messing Professor of Pathology and Immunology
Expertise: Experimental biology, therapeutic cloning, osteoporosis, bone degeneration, bone disease
Bio:
 |
| Teitelbaum |
As the past president of the Federation of American Societies for Experimental Biology — the largest coalition of biomedical research associations in the United States — Teitelbaum is a strong supporter for therapeutic cloning. Somatic cell nuclear transfer, as it is also known, could hold the potential for helping and even curing millions of Americans suffering from diseases such as cancer, Parkinson's, heart disease and Alzheimer's. Teitelbaum says the scientific community has done a poor job explaining the concept of therapeutic cloning, which isn't a reproductive process, since no whole organism results. He says the promise of the research is that patients could use their own cells to ward off serious illnesses. Teitelbaum can explain some of the scientific challenges, realities and ethical implications of cloning.
| News Stories & Tip Sheets: |
Showing 2 Stories.
|
|
Why bones weaken
Medical steroid's baffling connection to osteoporosis becomes clearer
July 27,
2006 --
 |
| Dark areas (marked with arrows) in the first image show a process of bone renewal and strengthening. The second image shows a reduction in this process after a cortisone injection. |
Scientists are closing in on the solution to a persistent medical puzzle: why do high doses of cortisone, widely prescribed for asthma, rheumatoid arthritis and other inflammatory and autoimmune conditions, weaken bones? Researchers at the School of Medicine have identified osteoclasts, cells that dismantle old bone, as the essential link between osteoporosis and cortisone.
|
Building blocks
Scientists make case for federal funding of stem cell research
Oct. 20,
2005 --
Steven Teitelbaum, professor of pathology and immunology, was one of several experts invited to testify before a Senate Appropriations subcommittee, chaired by Senator Arlen Specter, regarding the benefits of stem cell research. Read Teitelbaum's testimony here.
|
Showing 2 Stories.
|
|
| Clips: |
Showing 1 Clips.
|
|
Stem cell bill gains steam
Chicago Tribune
and 16 others
May 17,
2005 -- Armed with fresh hope of overturning President Bush's limits on federal funding for embryonic stem cell studies, Republican members of Congress held an unusual hearing in a Chicago courtroom Monday to rally support for expanding the controversial research. To counter the argument that adult cells are valid alternatives, two researchers who specialize in adult stem cells — including WUSTL's Steven Teitelbaum — were invited to explain the advantages of embryonic cells.
|
|
| |
|
Download
Email this page
Print ready page